[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
[ Mon, Apr 15th 2024 ]: WOPRAI
Matthew Sykes Maintained (VCYT) at Strong Buy with Decreased Target to $28 on, Apr 15th, 2024
- 🞛 This publication is a summary or evaluation of another publication
Matthew Sykes of Goldman Sachs, Maintained "Veracyte, Inc." (VCYT) at Strong Buy with Decreased Target from $32 to $28 on, Apr 15th, 2024.
Matthew has made no other calls on VCYT in the last 4 months.
There are 2 other peers that have a rating on VCYT. Out of the 2 peers that are also analyzing VCYT, 0 agree with Matthew's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Matthew
- Tejas Savant of "Morgan Stanley" Maintained at Sell with Decreased Target to $21 on, Monday, February 26th, 2024
- Mike Matson of "Needham" Maintained at Strong Buy with Increased Target to $33 on, Friday, February 23rd, 2024